Revolution Medicines (RVMD) stock soared 38% after Phase 3 trial data showed daraxonrasib doubled survival in pancreatic cancer patients versus chemotherapy.
Browsing: Stocks
Intel (INTC) stock has tripled in a year, up 69% in 2026. Tesla’s Terafab deal and Google AI partnership drive analyst targets as high as $92.
Kering (PRTP) stock dropped 3% after Morgan Stanley’s downgrade to equal-weight, slashing targets on Gucci recovery doubts days before Q1 earnings.
Nebius (NBIS) downgraded to Hold by Freedom Capital after 70% surge in two months. Price target raised to $154 amid valuation concerns.
Archer Aviation (ACHR) stock jumped 378% in three months. Discover what’s fueling the rally, from FAA eIPP selection to Starlink integration.
JPMorgan advises investors to buy during market dips, citing strong S&P 500 earnings growth, cooling inflation, and 34% discount in emerging markets.
Leggett & Platt (LEG) stock rises 5.7% as Somnigroup announces $2.5B all-stock acquisition. Deal expected to close by end of 2026 pending approval.
KeyBanc upgrades T-Mobile (TMUS) to Overweight with $260 price target, seeing 33% upside potential from AI investments and EBITDA growth opportunities.
Stock futures fell sharply and oil prices topped $100 as Trump ordered a Navy blockade of the Strait of Hormuz after Iran peace talks collapsed.
Goldman Sachs (GS) shares climb after crushing Q1 expectations with $5.63B earnings, record equities revenue, and 48% surge in investment banking fees.